Get started
Author

Ke Lian

Observed name: K. Lian
ORCID: 0000-0001-9565-8486
Observed ORCID: 0000-0001-9565-8486
OpenAlex ID: A5040030235
Circular RNA circ_0000284 plays an oncogenic role in the progression of non-small cell lung cancer through the miR-377-3p-mediated PD-L1 promotion
2020 · Li Li, Qiaohua Zhang, et al. · Cancer Cell International · 60
PDF
Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic era
2023 · Tingting Zhang, Weiwei Tian, et al. · Experimental Hematology and Oncology · 19
PDF
Risk Factors of Thromboembolism in Lymphoma Patients Undergoing Chemotherapy and its Clinical Significance
2021 · Xiao Li, Shu-Ling Hou, et al. · Clinical and Applied Thrombosis/Hemostasis · 7
PDF
Prognostic value of 18F-FDG PET/CT tumor metabolic parameters and Ki-67 in pre-treatment diffuse large B-cell lymphoma
2023 · Huixia Geng, Ke Lian, et al. · Quantitative Imaging in Medicine and Surgery · 3
Investigation into the prognostic factors of early recurrence and progression in previously untreated diffuse large B-cell lymphoma and a statistical prediction model for POD12
2025 · Ke Lian, Wenyao Zhu, et al. · Frontiers in Immunology · 2
PDF
Prognostic evaluation of system immune-inflammatory index and prognostic nutritional index in double expressor diffuse large B-cell lymphoma
2023 · Fang Su, Ke Lian · Open Medicine · 1
PDF
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma
2022 · Ke Lian, Qiao-Hua Zhang, et al. · Asian Journal of Surgery · 1
PDF
[Clinical Value of Serum Amyloid A and Misfolded Transthyretin for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients].
2020 · Hu Liu, Shu-Ling Hou, et al. · PubMed · 1
[Effect of P53 Expression on Prognosis of Patients with Double Expressor Lymphoma].
2019 · Xin Ding, Shu-Ling Hou, et al. · PubMed · 1
[Asian variant of intravascular large B cell lymphoma with leukemia：a case report and literature review].
2015 · Xiangle Xiong, Shuling Hou, et al. · PubMed Central · 1
A retrospective study at a single center examining risk factors associated with central nervous system involvement in individuals diagnosed with diffuse large B-cell lymphoma
2024 · Wei Chen, Hu Liu, et al. · Clinical Neurology and Neurosurgery
[Risk Factors Analysis of Thromboembolism in Patients with Lymphoma Chemotherapy].
2022 · Xiao Li, Shu-Ling Hou, et al. · PubMed
Primary CD5+ diffuse large B-cell lymphoma with hyperlactatemia as the first manifestation
2021 · K. Lian · Journal of Biological Regulators and Homeostatic Agents/Journal of Biological Regulators & Homeostatic Agents
Expressions of serum tumor markers in patients with diffuse large B-cell lymphoma and their clinical significances
2018 · Xiaoqiang Xu, Zhihua Xing, et al. · 白血病·淋巴瘤
Castleman disease: report of five cases and review of literature
2017 · Shuying Liu, Shuling Hou, et al. · 白血病·淋巴瘤
Synchronous angioimmunoblastic T cell lymphoma and primary gastric cancer: a case report and literature review
2016 · Chen Qiu, Qiaohua Zhang, et al. · 肿瘤研究与临床
Relationship of serumCA125 and VEGF with infiltration of NHL cells to bone marrow
2010 · Ke Lian, Minjie Wu, et al. · 白血病·淋巴瘤
Works count: 17
Citation count: 96
H-index: 3
I10-index: 2
Year
Topic
Type